Evidence map›Paper›PMID 29723473›Full record

ArticleBioconjugate chemistry2018

Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.

Karim Rafie, Andrii Gorelik, Riccardo Trapannone, Vladimir S Borodkin, Daan M F van Aalten

Open access · hybridAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Advances in chemical probing of proteinChemical Society reviews · 2021
    Review
  9. Review
  10. Overview of the Assays to ProbeMolecules (Basel, Switzerland) · 2021
    Review
  11. Molecular Interrogation to Crack the Case of O-GlcNAc.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Karim RafieDivision of Gene Regulation and Expression, School of Life Sciences , University of Dundee , DD1 5EH Dundee , U.K.ORCID 0000-0003-2418-0061
Andrii GorelikDivision of Gene Regulation and Expression, School of Life Sciences , University of Dundee , DD1 5EH Dundee , U.K.
Riccardo TrapannoneDivision of Gene Regulation and Expression, School of Life Sciences , University of Dundee , DD1 5EH Dundee , U.K.
Vladimir S BorodkinDivision of Gene Regulation and Expression, School of Life Sciences , University of Dundee , DD1 5EH Dundee , U.K.ORCID 0000-0002-8479-3188
Daan M F van AaltenDivision of Gene Regulation and Expression, School of Life Sciences , University of Dundee , DD1 5EH Dundee , U.K.
University of Dundee · GB

Funding

Wellcome TrustWellcome Trust WT087590MA
6 · The paper itself

Abstract

O-GlcNAc transferase (OGT) is an essential glycosyltransferase that installs the O-GlcNAc post-translational modification on the nucleocytoplasmic proteome. We report the development of S-linked UDP-peptide conjugates as potent bisubstrate OGT inhibitors. These compounds were assembled in a modular fashion by photoinitiated thiol-ene conjugation of allyl-UDP and optimal acceptor peptides in which the acceptor serine was replaced with cysteine. The conjugate VTPVC(S-propyl-UDP)TA ( K

Indexed as

Drug DesignEnzyme InhibitorsHeLa CellsHumansMolecular Docking SimulationN-AcetylglucosaminyltransferasesPeptidesSulfhydryl CompoundsUridine DiphosphateEnzyme InhibitorsN-AcetylglucosaminyltransferasesO-GlcNAc transferasePeptidesSulfhydryl CompoundsUridine Diphosphate

Identifiers

PMID29723473
PMCPMC6016062
OpenAlexW2801169841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.